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 There is a need of a lower profile device of transcatheter heart valves.  One way to 
simply achieve this task is to decrease the size of the device by using a thinner bovine 
pericardium.  The devices currently use calf bovine pericardium which is reported to have 
a higher tissue thickness compared to that of fetal bovine pericardium.  This provided the 
opportunity to test fetal bovine pericardium as a viable alternative.  Uniaxial testing and 
histology were performed to determine the mechanical and structural properties of both 
groups (n=10 for each group). We report a statistical difference in ultimate tensile strength 
and strain at failure between both groups but no statistical difference was found for 
collagen composition between the two groups.  With these results, we are unable to prove 
fetal bovine pericardium to be a viable alternative.  However, there were a couple of 
outliers from the fetal bovine pericardium had smaller thickness that showed higher 
ultimate tensile strength and strain at failure compared to those of calf bovine pericardium.  
In the future, it would provide an opportunity in developing lower profile device by further 








Cardiovascular disease remains the number one cause of death1, and among 
industrialized nations, calcific aortic valve disease (CAVD) is the most prevalent form of 
cardiovascular disease. Traditionally, surgical aortic valve replacement (SAVR) has been 
the gold standard for treatment of CAVD, however, over the past decade, transcatheter 
aortic valve replacement (TAVR) has emerged as a viable alternative for high-risk patients 
who have been excluded from surgical candidacy due to comorbidities2. TAVR uses a 
transfemoral or transapical catheter approach to deploy a balloon-expandable or self-
expanding stent attached to artificial heart valve leaflets constructed from calf bovine 
pericardium (CBP) or porcine valve tissue. 
The use of smaller low-profile valves and catheter systems allows for smaller 
incisions and easier advancement of the catheter and valves through small and/or tortuous 
arteries. However, the size of the valve and the delivery catheter systems are limited by the 
thickness of the tissue used in the valve leaflets and the crimping profile of the stent. The 
Edwards SAPIEN transcatheter heart valve and the Medtronic CoreValve represent two of 
the most commonly used TAVR devices. The SAPIEN valve is available in two sizes, 23 
mm and 26 mm, and uses transfemoral delivery with sheaths of 22 Fr and 24 Fr internal 
diameters, respectively2. A newer SAPIEN XT valve utilizes a new leaflet geometry 
allowing for 16 Fr and 19 Fr delivery sheaths. The next-generation SAPIEN 3 valves 
further reduces the device profile allowing for delivery sheaths as small as 14 Fr. The 
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Medtronic CoreValve and CoreValve Evolut both utilize an 18 Fr delivery sheath for 
transfemoral access for all valve sizes. 
 In the rapidly growing field of TAVR devices it is clear that the industry is trending 
towards lower-profile devices that minimize incisions to access vessels, facilitate easier 
advancement of TAVR devices to the aortic annulus and minimize major vascular 
complications (vascular dissection, perforation and access-site hematoma). The objective 
of this study is to investigate an alternative material to use in transcatheter heart valves 
manufacture that exhibits a similar mechanical response to CBP, despite having a 
decreased thickness. It is hypothesized that fetal bovine pericardium (FBP) can offer 
similar mechanical properties and morphology with much lower thickness compared to 
CBP. 
Literature Review 
Among cardiovascular diseases, calcification of aortic valve is the most common 
cause of aortic stenosis in adults more than 75 years old in industrialized countries. 
However, calcification of aortic valve rarely occurs in people less than 50 years of age3.  
Traditionally, the gold standard for treating aortic stenosis is surgical aortic valve 
replacement2.  Unfortunately, SAVR is, in many cases, not a viable option in the old 
patient, which is the group where calcific aortic valve disease is most prevalent. These 
patients are considered unsuitable for SAVR because of the high risk involved in open-
heart surgery. Physicians often do not offer this method or patients themselves refuse the 
surgery4.  As a viable alternative to SAVR, TAVR is offered for those high-risk patients 
who have been excluded from surgical candidacy3,4. TAVR is an evolving technology and 
medical procedure that has been developed with high-risk and inoperable patients suffering 
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from calcific aortic valve disease or calcific aortic stenosis.  The Edwards SAPIEN 
transcatheter heart valve is one of the most commonly used TAVR devices. The SAPIEN 
valve is available in two sizes, 23 mm and 26mm2. The use of smaller low-profile valves 
and catheter systems allows for smaller incisions and easier advancement of the catheter 
and valves through small and/or tortuous arteries. However, the size of the valve and the 
delivery catheter systems are limited by the thickness of the tissue used in the valve leaflets 
and the crimping profile of the stent. Up to this point, calf bovine pericardium is the most 
commonly used bioprosthetic heart valve (BHV) and little research has been done 
investigating the use of FBP as an alternative5.  FBP has a lower thickness compared to 
CBP. By proving FBP as a viable replacement for CBP as a BHV, smaller low-profile 
valves are possible, thereby improving the quality of life of the patients and introducing 
the technology to a broader group.    
As valve replacement surgery outcomes are generally very good, there is almost no 
contraindication to valve replacement for aortic stenosis6.  However, older patients have 
more comorbidity, and they are unlikely to survive open-heart surgery. A study by Iung et 
al. has shown that surgery is denied in as many as 33% of elderly candidates7.  Therefore, 
it is crucial to prove that TAVR is in fact a viable alternative to the traditional golden 
standard for aortic valve replacement. There have been a number of clinical trials from 
different countries, including randomized trials comparing TAVR to classical aortic valve 
replacement8.  
Cribier’s research in 2002 provides the results of the first TAVR of aortic valve 
prosthesis for calcific aortic stenosis9. This study was performed in order to identify 
patients’ health after they received TAVR.  Although the study had a limited sample size 
 4 
and is considered to be a single-center study, it was a good study and presented hopeful 
results. In 2010, the largest TAVR registry in Europe at that time was created in France2.  
A total of 3195 patients were enrolled and Edwards SAPIEN systems were implanted.  
Gilard et al. reported the results of this prospective multicenter study.  The survival rate in 
this archive resembled the rates in the SOURCE Registry, UK registries, and cohort A of 
the PARTNER Trial (Placement of AoRtic TraNscathetER Valves)10. The PARTNER trial 
was the world’s first randomized and controlled study to test the safety and effectiveness 
of transcatheter heart valves and the delivery system in people with severe aortic stenosis. 
This trial had two groups: the high-risk operable patient (cohort A) and the extreme-risk or 
inoperable patient (cohort B). The high-risk patients were randomized to TAVR or sAVR. 
The results of these studies come to the conclusion that TAVR is not inferior to classical 
aortic valve replacement in terms of procedure success and short-term morbidity and 
mortality.  
Unfortunately, TAVR is not a perfect solution for every patient.  Like any new procedure, 
TAVR is associated with predictable and unanticipated complications.  One of the most 
common complications is the vascular complication, which may contribute to procedural 
mortality11. This is particularly true of the transfemoral approach where the valve and 
catheter are inserted via the femoral artery.  The risk is greatest in patients with significant 
peripheral vascular disease and vascular injury is related to the large-caliber sheaths used 
for device deployment12.  These probable vascular injuries may lead to significant bleeding 
at the insertion site and even lead to mortality. There is an effort in miniaturizing the valves 
in hopes of decreasing the rate of vascular complications. Bovine pericardium is used for 
heart valve leaflet replacement where the strength and thinness are critical properties. 
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Several researches have been conducted focusing on the type of tissue used in such devices.  
Sizeland et al. focused on pericardium from neonatal animals (4–7 days old.) Their thinner 
pericardium is considered as an alternative to the valves used in current devices13.  This 
study shows that the tissue of neonatal animals shares mechanical properties and collagen 
structures that are compliant to those of adults or calves. However, this study fails to 
quantify the different types of collagen present in the tissue.  Bovine pericardium is a 
fibrous collagen extracellular matrix material with structural similarities to skin and other 
tissues14.   According to Julkenen’s study, methods have been used to study collagen fibril 
orientation using polarized light microscopy15.  And it is found that there exists a function-
structure relationship between collagen alignment and mechanical strength16.  Collagen 
tissue properties change over time and tissue strength varies depending on the collagen 
fibril diameter17.  The structural differences between calf bovine pericardium and fetal 
bovine pericardium tissue that may present desirable differences in their physical properties 
have not been adequately investigated.  This study investigated the structural differences 








The bovine pericardium tissues were transported to the laboratory in cold isotonic 
saline (0.9% sodium chloride).  Any extraneous fat was removed from the tissues.  Then 
these tissues were mounted in a framed and immersed in a 0.65% glutaraldehyde solution 
in a phosphate buffer at pH 7.4.  The patches were then sterilized in a solution of 2% 
glutaraldehyde, 4% formaldehyde and 20% ethanol in the same pH 7.4 buffer for 24 hours. 
The sheets of pericardium were trimmed to dimensions predetermined by the manufacturer 
and placed in a container with 0.25% glutaraldehyde for storage. Before storing the tissues, 
the thickness of each tissue fragment was recorded by measuring a series of ten points, 
using a Mitutoyo micrometer (elecount, series E:A33/8 Digital).  All of the trials were 
carried out at room temperature of 22 to 24°C. 
 
Uniaxial Testing 
Cutting and Marking Samples 
 The bovine pericardium tissues were cut into a dog-bone shape.  This was done so 
that the when testing, the rupture will occur in the center of the sample where data 
acquisition is optimal.  Then we placed four small markers on the sample to track its 
elongation/strain using Labview during image analysis.  Figure 1 shows a representation 





 Before testing the samples until rupture, each sample went through a process of 
preconditioning.  Preconditioning went through ten cycles of slightly stretching and 
relaxing the tissue using a preprogrammed command of the linear actuator (TestResources 
200Q Universal Electromechanical Test Machine) at a displacement rate of 50 mm/min.  
The amount of load of stretching was determined by 10% of maximum load before 
rupturing the sample.  Preconditioning the sample was performed in order to imitate real 
life conditions. 
Uniaxial Testing 
 Immediately after precondition the samples, the specimens were loaded to failure 
at a displacement rate of 50 mm/min. The ultimate tensile strength (UTS) and failure strain 
were defined by the peak stress and maximum deformation withstood by the specimens 
prior to failure.  Stress was calculated by dividing the recorded load by the cross-sectional 
area of the sample determined prior of the testing.  Stress vs. strain curves were plotted and 
analyzed using a Matlab script.   
 




Ten samples from each group, CBP and FBP, were cut into a 2 to 3 mm wide and 
15 mm long rectangle from different locations of the bovine pericardium tissue.  The next 
step was to place these samples in a small plastic box filled with OCT (shown in Figure 2) 
which is a freezing medium that helps protect the tissue drying and supports the tissue 
while sectioning. Then plastic boxes were placed in a Styrofoam container and poured 
liquid nitrogen for at least ten minutes (Figure 3).  Once frozen, samples were taken out of 
the box and sliced the samples for 5µm using the Cryostat (Thermo Scientific CryoStar 













Figure 2. Samples placed in OCT compound prior to freezing (left).  
 .Sample blocks after freezing (right). 
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Staining 
These slides were then stained in Picro-Sirius Red solution for one hour. This gives near-
equilibrium staining and shorter times should not be used even if the colors look okay.  The 
next procedure was to rinse the slides in two changes of acetic acid solution and 
dehydrating in three changes of 100% alcohol.  After dehydrating the slides, they were 
cleared with 2-3 changes of xylene and applied a coverslip over the slide using resinous 
mounting medium.  Picro-Sirius stain is used to stain collagen present in the tissues.  
Studies show that using Picro-Sirius red stain enhances the detection of collagen when in 
use of polarized microscopy.  Using this stain also shows different colors between collagen 
Type I and collagen Type III18.   
Microscopic observation 
 Once the mounting medium was completely dried, the specimens were observed 
under polarized light using bright field microscope (Zeiss Scope. A1 Axio). Larger 
collagen fibers are bright yellow or orange, and the thinner ones, including reticular fibers, 
are green19.  
Color Quantification 
  Images were processed using ImageJ for a clearer background.  The color 
composition of red, orange, yellow and green was calculated by using Matlab in order to 
determine the samples’ different types collagen composition. We only recorded the hue 
component that contained 256 possible colors.   First we defined the hue values for the 
specific colors.  Red: hue values 2-9 & 230-256; orange: hue values 10-38; yellow: hue 
values 39-51; and green: hue values 52-12820.  Any hue values that were not included was 
considered to be interstitial space confirmed by inspection.  We determined the number of 
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pixels for each hue range and added the them all up to express the total collagen content.  
Then we calculated the composition for each color by dividing the number of pixels for 







Tissue Thickness and Maximum Load 
 The following table shows data of the tissue thickness and maximum load (Table 
1). The average thickness as well as the average of maximum load were greater with the 
calf bovine pericardium.   Statistical test comparing the thickness between the CBP and 
FBP using a simple t-test (P≤ 0.001) and showed a significant difference between the 











Sample Thickness (mm) Load (g) Sample Thickness (mm) Load (g) 
CBP 1 0.3 1319 FBP 1 0.235 598 
CBP 2 0.367 1940 FBP 2 0.23 356 
CBP 3 0.332 1353 FBP 3 0.245 600 
CBP 4 0.347 1285 FBP 4 0.22 784 
CBP 5 0.302 1344 FBP 5 0.26 838 
CBP 6 0.29 2111 FBP 6 0.235 363 
CBP 7 0.277 1425 FBP 7 0.195 325 
CBP 8 0.312 2075 FBP 8 0.23 711 
CBP 9 0.337 1031 FBP 9 0.225 859 
CBP 10 0.35 2035 FBP 10 0.235 431 
Table 1. Tissue Thickness and Maximum Load of CBP and FBP. 
Figure 3. Tissue Thickness of CBP and FBP. 
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Figure 4. Stress vs Strain curve of CBP (top) and FBP (bottom). 
Ultimate Tensile Strength and Strain of Failure 
 Ultimate tensile strength (UTS) and strain at failure were determined of the 
maximum stress and deformation prior to failure, respectively, by examining the stress vs 
strain curve of each sample.  Figure 4 represents a stress vs strain curve of CBP and FBP.  
A simple t-test was performed (P≤ 0.001) between the CBP and FBP of UTS (mean: 
22.438, 12.324; standard deviation: 5.619, 4.352, respectively.) and strain of failure (mean: 
0.460, 0.608; standard deviation: 0.0901, 0.0704, respectively) determined a statistically 












































Sample UTS (MPa) Strain  Sample 
UTS 
(MPa) Strain 
CBP 1 21.26 0.5956 FBP 1 12.88 0.6993 
CBP 2 23.22 0.4036 FBP 2 11.72 0.5749 
CBP 3 19.03 0.5208 FBP 3 17.75 0.6837 
CBP 4 16.31 0.4074 FBP 4 16.31 0.7002 
CBP 5 20.92 0.5346 FBP 5 14.49 0.5286 
CBP 6 33.54 0.4945 FBP 6 18.61 0.6114 
CBP 7 21.84 0.3437 FBP 7 8.59 0.5292 
CBP 8 28.31 0.3486 FBP 8 7.45 0.5862 
CBP 9 24.73 0.3994 FBP 9 7.79 0.5252 





















Table 2. UTS and strain at failure for CBP and FBP. 
Figure 5. Statistically significant difference was found using t-test  (P≤ %. %%&) for 
both UTS and strain at failure between the groups. 
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Collagen Composition 
 Images were taken using polarized light to identify collagen compositions (Figure 
6).  It was determined that there were no statistical differences between the two groups of 
the colors red, orange and yellow.  However, there was a statistical difference (P=0.008) 










Figure 6. Image of CBP4 (left) and FBP7 (right) taken under polarized light after staining 




































Figure 7. No statistical difference found for red, orange and yellow. Significant 






 We conducted uniaxial testing in order to find the mechanical properties of bovine 
pericardium.  We looked at the ultimate tensile strength and strain at failure to identify 
mechanical properties of each group.  Given the significant differences in ultimate tensile 
strength and strain at failure between CBP and FBP (P≤ 0.001), and the fact that they had 
significant differences in thickness as well, it was determined that the two groups had 
different mechanical properties.  It was observed that the ultimate tensile strength differed 
almost twice (CBP: 22.438 MPa and FBP: 12.324MPa) but only differed less than 30% in 
tissue thickness (CBP: 0.3214 mm and FBP: 0.2312 mm).  Looking at the results we can 
see that with higher thickness associates a higher ultimate tensile strength ranging from 14 
MPa to over 33 MPa.  However, there is also a trend of decreasing strain at failure with 
increasing ultimate tensile strength (Figure 8).  We can interpret this data as for the tissues 






 Histology was performed to identify structural properties of bovine pericardium.  
We used Picro Sirius to stain the tissue samples to look at their collagen compositions 
under polarized light. Studies show that using Picro-Sirius stain enhances the detection of 
collagen when in use of polarized microscopy. We calculated the percent composition of 
the specific colors as follows: CBP (Red: 28.09%, Orange: 59.53%, Yellow: 2.67%, Green: 
0.81%) FBP (Red: 27.87%, Orange: 65.90%, Yellow: 4.36%, Green: 1.36%).  The color 
orange had the most collagen composition having nearly or over 60% for both bovine 
groups.  There was no statistically significant difference found between them.  The least 
composition was found in the color green which composed less than 2% of the whole 
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 In this study, two types of bovine pericardium were tested through uniaxial testing 
and and histology to identify its viability of an alternative material for prosthetic heart 
valves.   We hypothesized that calf and fetal bovine pericardium will have similar 
mechanical and structural properties.  However, though the experiment it was shown that 
there was a significant difference in mechanical properties between the two groups.  Our 
hypothesis was rejected and we did not have sufficient data to show that FBP can be a 
viable alternative for CBP used in prosthetic heart valves although they had similar 
collagen compositions.  
 
Future Work 
 Although we tried to emulate real life conditions during our testing, the tissue 
sample was constantly exposed in air during uniaxial testing.  In the future, we wish to 
perform this test similar to the real life conditions.  When cutting the tissues into dog-bone 
shapes, we did not consider the orientation of the fibers.  We think that the orientation of 
fiber, whether cut perpendicularly or in parallel, will affect the results.  We have identified 
incidents where samples from FBP having lower thicknesses compared to that of CBP 
actually had higher ultimate tensile strength and strain at failure.  Further investigating this 





1.! World Health Organization. Cardiovascular diseases. 
http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed January 2015. 
2.! Lachell, A., Henry, L. Transcatheter aortic valve replacement options for severe 
aortic stenosis in high-risk patients. J Cardiovasc Nurs, 30(3), 242-247. 2015. 
3.! O'Brien, K. D. Epidemiology and genetics of calcific aortic valve disease. Journal 
Of Investigative Medicine: The Official Publication Of The American Federation 
For Clinical Research, 55(6), 284-291. 2007 
4.! Ozkan, A. et al. Assessment of left ventricular function in aortic stenosis. Nature 
Reviews. 8(9), 494-501. 2011. 
5.! Singhal, P. et al.  Bioprosthetic Heart Valves: Impact of Implantation on 
Biomaterials. ISRN Biomaterials, 2013, 1-14. 2013. 
6.! Kurtz, C. E., & Otto, C. M. (2010). Aortic stenosis: clinical aspects of diagnosis 
and management, with 10 illustrative case reports from a 25-year experience. 
Medicine, 89(6), 349-379 
7.! Iung, B., Cachier, A., Baron, G., Messika-Zeitoun, D., Delahaye, F., Tornos, P., . . 
. Vahanian, A. (2005). Decision-making in elderly patients with severe aortic 
stenosis: why are so many denied surgery? Eur Heart J, 26(24), 2714-2720 
8.! Pasic, M., Unbehaun, A., Dreysse, S., Drews, T., Buz, S., Kukucka, M., . . . 
Hetzer, R. (2010). Transapical aortic valve implantation in 175 consecutive 
patients: excellent outcome in very high-risk patients. J Am Coll Cardiol, 56(10), 
813-820 
 20 
9.! Pasic, M., Unbehaun, A., Dreysse, S., Drews, T., Buz, S., Kukucka, M., . . . 
Hetzer, R. (2010). Transapical aortic valve implantation in 175 consecutive 
patients: excellent outcome in very high-risk patients. J Am Coll Cardiol, 56(10), 
813-820 
10.!Gilard, M. et al. Registry of transcatheter aortic valve implantation in high-risk 
patients. The New England Journal of Medicine. 2012. 
11.!Windecker, S. Clinical outcome and predictors for adverse events after 
transcatheter aortic valve implantation with the use of different devices and 
access routes. Am Heart J, 161(6), 1114-1124. 2011. 
12.!Fishbein, G. A. et al. Transcatheter aortic valve implantation: status and 
challenges. Cardiovasc Pathol, 23(2), 65-70. 2014.  
13.!Sizeland, K. H. et al. Age dependent differences in collagen alignment of 
glutaraldehyde fixed bovine pericardium. Biomed Res Int. 2014. 
14.!Sizeland, Katie et al. Age dependent differences in collagen alignment of 
glutaraldehyde fixed bovine pericardium. BioMed Research International. 2014 
15.!Julkunen et al. Maturation of collagen fibril network structure in tibial and 
femoral cartilage of rabbits. Osteoarthritis Cartilage. 18(3):406-15. 2010 
16.!Fratzl et al. Nature's hierarchical materials. Progress in Materials 
Science. 52(8):1263–1334. 2007 
17.!Willet, TL. Changes in collagen with aging maintain molecular stability after 
overload: evidence from an in vitro tendon model. J Bimech Eng. 2010 
 21 
18.!Junqueria, L.C.U. et al. Picrosirius staining plus polarization microscopy, a 
specific method for collagen detection in tissue sections. Histochemcial Journal. 
(11) 447-455. 1979.  
19.!Kiernan, John A. Sirius Red for collagen staining protocol. Department of 
Anatomy and Cell Biology.  
20.!Aikawa,E. et al. Human semilunar cardiac valve remodeling by activated cells 
from fetus to adult: Implications for postnatal adaption, pathology, and tissue 
engineering. Circulation: Journal of the American Heart Association. 2006. 
21.! 
